Baerveldt Versus Paul Study
NCT: NCT07733453 · NOT_YET_RECRUITING
Brief Summary
The Baerveldt Versus Paul (BvP) Study is a Registry-based Randomised Controlled Trial, Comparing the Baerveldt Glaucoma Implant (BGI) and the Paul Glaucoma Implant (PGI). Participants will Include patients requiring aqueous shunt surgery for control of intraocular pressure and glaucoma. The objective of this study is to compare the long-term safety and effectiveness of placement of a BGI and PGI for patients who are undergoing aqueous shunt implant surgery. Patients who qualify for the study are randomized to receive either a BGI or PGI aqueous shunt.
Frequently Asked Questions
What is Baerveldt Versus Paul Study?
Baerveldt Versus Paul Study is a clinical trial registered under NCT07733453. Current status: NOT_YET_RECRUITING.
What is the status of NCT07733453?
The current status of NCT07733453 (Baerveldt Versus Paul Study) is: NOT_YET_RECRUITING.
When did Baerveldt Versus Paul Study start?
Baerveldt Versus Paul Study started on 2026-10-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.